ArticleEuropean journal of medical research2023

PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics.

Tongtong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.